Interaction of adipokines and hepatitis B virus on histological liver injury in the chinese

American Journal of Gastroenterology

Volumn 105, Issue 1, 2010, Pages 132-138

  Wong, Vincent Wai Sun ^a   Wong, Grace Lai Hung ^a   Yu, Jun ^a   Choi, Paul Cheung Lung ^a   Chan, Anthony Wing Hung ^a   Chan, Hoi Yun ^a   Chu, Eagle Siu Hong ^a   Cheng, Alfred Sze Lok ^a   Chim, Angel Mei Ling ^a   Chan, Francis Ka Leung ^a   Sung, Joseph Jao Yiu ^a   Chan, Henry Lik Yuen ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INSULIN; INTERLEUKIN 6; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ADULT; ARTICLE; CHINESE; CHRONIC HEPATITIS; COHORT ANALYSIS; CONTROLLED STUDY; FATTY LIVER; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INSULIN RESISTANCE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS HEPATITIS;

ADIPOKINES; ADIPONECTIN; ADULT; BIOPSY; CHINA; FATTY LIVER; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; LEPTIN; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESISTIN; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73849152395     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.560     Document Type: Article

References (37)

1. Chan HL, Sung JJ. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis 2006;26:153-161
2. Liaw Y F, Sollano JD. flactors in fluencing liver disease progression in chronic hepatitis B. Liver Int 2006;26:23-29
3. Wong G L, Wong V W, Choi P C et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009; 58: 111-117
4. Lai M S, Hsieh M S, Chiu Y H et al. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology 2006;43:1295-1302
5. Yu M W, Shih W L, Lin C L et al. Body-mass index and progression of hepatitis B: a population-based cohort study in men. J Clin Oncol 2008;26:5576-5582
6. Hui JM, Hodge A, Farrell G C et al. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004; 40: 46-54.
7. Wong V W, Hui A Y, Tsang SW et al. Metabolic and adipokine prof le of Chinese patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006; 4: 1154-1161
8. Xu A, Wang Y, Keshaw H et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003;112:91-100.
9. Crespo J, Cayon A, Fernandez-Gil P et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001;34:1158-1163
10. Peng D, Han Y, Ding H et al. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors. J Gastroenterol Hepatol 2008;23:1082-1088
11. Shi J P, Fan J G, Wu R et al. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J Gastroenterol Hepatol 2008;23:1419-1425
12. Alberti K G, Zimmet P, Shaw J. The metabolic syndrome--a new worldwide defnition. Lancet 2005;366:1059-1062
13. Chan H L, Chui A K, Lau W Y et al. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence afer liver transplantation. J Med Virol 2002;68:182-187
14. Chan H L, Tsang SW, Wong M L et al. Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong. Am J Gastroenterol 2002;97:2629-2633
15. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699
16. Zylberberg H, Rimaniol A C, Pol S et al. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological f brosis and activity. J Hepatol 1999;30:185-191
17. Crespo J, Rivero M, Fabrega E et al. Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fbrosis. Dig Dis Sci 2002;47:1604-1610
18. Maeno T, Okumura A, Ishikawa Thet al. Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2003;18:1358-1363
19. Song Z, Zhou Z, Uriarte S et al. S-adenosylhomocysteine sensitizes to TNF-alpha hepatotoxicity in mice and liver cells: a possible etiological factor in alcoholic liver disease. Hepatology 2004;40:989-997
20. Wong V W, Wong G L, Tsang S W et al. Genetic polymorphisms ofladiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people. J Gastroenterol Hepatol 2008; 23: 914-921
21. Akriviadis E, Botla R, Briggs W et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 1637-1648
22. Satapathy SK, Garg S, Chauhan R et al. B en eficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004;99:1946-1952
23. Sun Z, Klein AS, Radaeva S et al. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology 2003;125:202-215
24. Naugler WE, Sakurai T, Kim S et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007;317:121-124
25. Wong V W, Yu J, Cheng A S et al. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer 2009; 124: 2766-2770
26. Liu S, Tinker L, Song Y et al. A prospective study of inflammatory cy-tokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 2007;167:1676-1685
27. Larter CZ, Farrell GC. Insulin resistance, adiponectin, cytokines in NASH: which is the best target to treat? J Hepatol 2006;44:253-261
28. Masaki T, Chiba S, Tatsukawa H et al. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepa-tology 2004;40:177-184
29. Jan C F, Chen C J, Chiu Y H et al. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10). Int J Obes (Lond) 2006;30:794-799
30. Luo B, Wang Y, Wang K. Association of metabolic syndrome and hepatitis B infection in a Chinese population. Clin Chim Acta 2007;380:238-240
31. Kumar M, Choudhury A, Manglik N et al. Insulin resistance in chronic hepatitis B virus infection. Am J Gastroenterol 2009; 104: 76-82.
32. Park SH, Kim DJ, Lee HY. Insulin resistance is not associated with histo-logic severity in nondiabetic, noncirrhotic patients with chronic hepatitis B virus infection. Am J Gastroenterol 2009;104:1135-1139
33. Hui C K, Zhang H Y, Lee N P et al. Serum adiponectin is increased in advancing liver f brosis and declines with reduction in f brosis in chronic hepatitis B. J Hepatol 2007;47:191-202.
34. Lu J Y, Su T C, Liu Y H et al. Lower plasma adiponectin is correlated to higher alanine aminotransferase independent of metabolic factors and hepatitis B virus carrier status. Intern Med J 2007; 37: 365-371
35. Cua I H, Hui J M, Bandara P et al. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Hepatology 2007; 46: 66-73.
36. Jonsson JR, Moschen A R, Hickman I J et al. Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol 2005;43:929-936
37. Valenti L, Fracanzani AL, Dongiovanni P et al. Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 2002;122:274-280